Analysts Conflicted on These Healthcare Names: Bristol-Myers Squibb (BMY) and Envista Holdings (NVST)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report) and Envista ...
The Globe and Mail22h
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was informed on Friday, November 1, 2024, of an updated ...
Business Insider22h
Waters (WAT) Gets a Hold from J.P. Morgan
Vatnsdal covers the Healthcare sector, focusing on stocks such as Myriad Genetics, Thermo Fisher, and Envista Holdings. Currently, the analyst consensus on Waters is a Hold with an average price ...